Treace Medical Concepts, Inc. TMCI Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $207.32M-1.7% | $212.69M+1.6% | $218.88M+7.9% | $213.75M+7.7% | $210.82M+7.5% | ||
| $42.05M+1.0% | $42.94M+4.5% | $44.05M+12.0% | $42.5M+10.7% | $41.64M+11.7% | ||
| $165.27M-2.3% | $169.75M+0.9% | $174.83M+6.9% | $171.25M+6.9% | $169.18M+6.6% | ||
| 79.7%-0.5pp | 79.8%-0.6pp | 79.9%-0.7pp | 80.1%-0.6pp | 80.2%-0.7pp | ||
| $19.34M-7.4% | $20.28M-1.5% | $20.95M+7.3% | $21.23M+12.2% | $20.89M+20.9% | ||
| $138.53M-3.4% | $140.88M-4.6% | $140.49M-6.8% | $138.84M-8.3% | $143.44M-2.8% | ||
| $63.13M+10.5% | $62.74M+12.6% | $61.83M+11.3% | $59.08M+8.0% | $57.15M+13.1% | ||
| $221.01M-0.2% | $223.91M0.0% | $223.26M-1.1% | $219.15M-2.6% | $221.48M+2.8% | ||
| $221.01M-0.2% | $223.91M0.0% | $223.26M-1.1% | $219.15M-2.6% | $221.48M+2.8% | ||
| -$55.74M-6.6% | -$54.15M+2.8% | -$48.44M+22.2% | -$47.89M+26.3% | -$52.3M+7.6% | ||
| -26.9%-2.1pp | -25.5%+1.1pp | -22.1%+8.6pp | -22.4%+10.3pp | -24.8%+4.1pp | ||
| $5.58M+6.3% | $5.32M+1.2% | $5.28M+0.7% | $5.26M+0.6% | $5.25M+1.0% | ||
| $2.44M-41.7% | $2.78M-43.1% | $3.15M-44.6% | $3.58M-42.1% | $4.18M-38.3% | ||
| -$5.3M-672% | -$4.85M-8,715% | -$1.67M-325% | -$1.29M-202% | -$687K-137% | ||
| -$61.04M-15.2% | -$59M-5.8% | -$50.11M+18.6% | -$49.18M+22.8% | -$52.99M+3.2% | ||
| -29.4%-4.3pp | -27.7%-1.1pp | -22.9%+7.4pp | -23%+9.1pp | -25.1%+2.8pp | ||
| -$0.96-12.9% | -$0.93-3.3% | -$0.80+19.2% | -$0.79+22.5% | -$0.85+3.4% | ||
| -$0.96-12.9% | -$0.93-3.3% | -$0.80+19.2% | -$0.79+22.5% | -$0.85+3.4% | ||
| 254.4M+2.1% | 252.5M+1.7% | 251.3M+1.8% | 250M+1.5% | 249.1M+1.4% | ||
| 254.4M+2.1% | 252.5M+1.7% | 251.3M+1.8% | 250M+1.5% | 249.1M+1.4% | ||
| -$61.12M-15.3% | -$59.03M-5.8% | -$50.22M+17.9% | -$49.11M+22.7% | -$53M+3.0% | ||
| $2.44M-41.7% | $2.78M-43.1% | $3.15M-44.6% | $3.58M-42.1% | $4.18M-38.3% | ||
| -$5.3M-672% | -$4.85M-8,715% | -$1.67M-325% | -$1.29M-202% | -$687K-137% | ||
| $577K+51.8% | $432K+33.3% | $462K+53.0% | $390K+27.9% | $380K+31.9% | ||
| -$55.74M-6.6% | -$54.15M+2.8% | -$48.44M+22.2% | -$47.89M+26.3% | -$52.3M+7.6% | ||
| -$46.68M-7.7% | -$43.53M+7.9% | -$38.38M+29.3% | -$38.46M+33.2% | -$43.33M+13.8% | ||
| -$46.68M-7.7% | -$43.53M+7.9% | -$38.38M+29.3% | -$38.46M+33.2% | -$43.33M+13.8% | ||
| -22.5%-2.0pp | -20.5%+2.1pp | -17.5%+9.2pp | -18%+11.0pp | -20.6%+5.1pp | ||
| -$55.74M-6.6% | -$54.15M+2.8% | -$48.44M+22.2% | -$47.89M+26.3% | -$52.3M+7.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Treace Medical Concepts, Inc.'s revenue?
- Treace Medical Concepts, Inc. (TMCI) generated $207.3M in revenue over the trailing twelve months, down 1.7% year over year.
- Is Treace Medical Concepts, Inc. profitable?
- Treace Medical Concepts, Inc. is not currently profitable: it reported a net loss of $61.0M over the trailing twelve months, a -29.4% net margin.
- What are Treace Medical Concepts, Inc.'s profit margins?
- Gross margin is 79.7% and operating margin is -26.9%, with a -29.4% net margin.
- What is Treace Medical Concepts, Inc.'s earnings per share?
- Treace Medical Concepts, Inc.'s diluted EPS over the trailing twelve months is $-0.96.
- Where does Treace Medical Concepts, Inc.'s income statement data come from?
- Every line is extracted from Treace Medical Concepts, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
